The Minnesota Twins are on the auction block. According to Sportico, the American League Central division team have retained investment bank Allen & Company to explore a sale of the franchise.

For Sale by Inventor works with inventors, retailers and consumers, with services ranging from patenting and research to selling products online. Invention services include product researching ...

We signed up with them in Nov 2023 for $1998 in order for them to market our timeshare for "rent" and to sell. We never received an offer until I contacted them to inquire about the status.

Advertisement New York City-based capital market company Allen & Company has been hired to facilitate the sale ... family’s heart and soul,” team owner Joe Pohlad said in a statement.

One of New Zealand’s biggest drug busts uncovered, the new policy threatening 20 years behind bars for Kiwis in Bali and Florida braces for another ferocious storm. A well-known Hawke’s Bay ...

SIOUX FALLS, S.D. (KELO) — The owners of the Minnesota Twins have announced they will explore selling the team. The Twins have been owned by the Pohlad family since 1984. The Twins Executive ...

Atlanta Falcons: Arthur Blank Blank has become among the NFL's most recognizable owners since purchasing the Falcons for $545 million in 2002. The sale came a year after Blank retired as co ...

The owners of The Cavalier Inn, Armadale, have put their beloved pub up for sale after more than four decades behind the helm A “well established” West Lothian pub has hit the market following ...

It had vanished for decades, and the FBI began investigating the pastel painting when it was listed for sale. The original owners, a Jewish couple in Austria named Adalbert and Hilda Parlagi ...

(Bloomberg) -- Stada Arzneimittel AG’s private equity owners are looking to expand the ... even as negotiations over a sale to buyout firm GTCR continue. Bain Capital and Cinven invited banks ...

(Bloomberg) -- Stada Arzneimittel AG’s private equity owners are looking to expand the bank lineup for a potential initial public offering of the German generic drugmaker, people familiar with the ...